Table 3. Correlation of TRPM2-AS expression and the clinicopathological characteristics of NSCLC patients.
| Variable | Number | TRPM2-AS level | P value | |
|---|---|---|---|---|
| High | Low | |||
| Age | 0.467 | |||
| ≤60 | 27 | 14 | 13 | |
| >60 | 33 | 14 | 19 | |
| Gender | 0.673 | |||
| Male | 36 | 16 | 20 | |
| Female | 24 | 12 | 12 | |
| Smoking status | 0.190 | |||
| Never | 29 | 11 | 18 | |
| Former Smoker | 31 | 17 | 14 | |
| Tumor size | 0.128 | |||
| ≤3 cm | 32 | 12 | 20 | |
| >3 cm | 28 | 16 | 12 | |
| Pleural invasion | 0.121 | |||
| No | 30 | 11 | 19 | |
| Yes | 30 | 17 | 13 | |
| Lymphatic invasion | 0.245 | |||
| No | 36 | 19 | 17 | |
| Yes | 24 | 9 | 15 | |
| Pathological stage | 0.061 | |||
| I | 27 | 9 | 18 | |
| II–IV | 33 | 19 | 14 | |
| EGFR-mutation | 0.009 | |||
| No | 21 | 5 | 16 | |
| Yes | 39 | 23 | 16 | |
NSCLC, non-small cell lung cancer; EGFR, epidermal growth factor receptor.